Large Clinical Trials and Registries—Clinical Research Institutes

作者: Robert M. Califf

DOI: 10.1016/B978-0-12-849905-4.00028-9

关键词:

摘要: As medical practice enters the era of “evidence-based medicine,” there is a growing need for high-quality scientific evidence to inform decisions made by physicians and other health care providers. However, pressures on existing clinical research enterprise are mounting. New diagnostic therapeutic technologies continue drive up costs, while at same time, resources evaluating such increasingly constrained. Clinician-researchers therefore must have thorough grasp strengths limitations various methods be able critically evaluate apply approaches both traditional novel. In this chapter, we will explore history, background, general concepts before moving address how results investigations expressed. We also examine trial design; ethical, legal, organizational aspects conducting research; application statistical methods, including meta-analyses systematic reviews; integration these into practice. Finally, visit current controversies in some possibilities future.

参考文章(125)
Lilienfeld Am, The Fielding H. Garrison Lecture: Ceteris paribus: the evolution of the clinical trial. Bulletin of the History of Medicine. ,vol. 56, pp. 1- 18 ,(1982)
R Collins, R Peto, M Flather, S Parish, P Sleight, M Conway, A Pipilis, C Baigent, D Barnett, JP Boissel, A Budaj, J Cairns, L Ceremuzynski, AF Cohen, Gui De Backer, R Diaz, F Dienstl, P Dove, MG Franzosi, M Genoni, DA Halon, J Heikkila, C Hennekens, J Horgan, D Hunt, R Kala, N Karatzas, A Keech, M Keltai, J Kjekshus, M Kornitzer, R Koster, P Landless, P Lechleitner, A Leizorovicz, BS Lewis, L Lundkvist, S Macmahon, A Maggioni, R Malacrida, T Meyer, T Moccetti, D Ocallaghan, E Paolasso, LS Piegas, A Reikvam, P Ridker, T Ryan, R Schroder, R Seabragomes, JEMR Sousa, G Tognoni, A Turpie, V Valentin, J Varigos, H White, L Wilhelmsen, K Woods, S Yusuf, A Piombo, LA Guzman, DC Montenegro, G Irusta, RA Schneider, C Cuneo, BH Chamorro, GE Espinosa, M Moreno, MM Rios, R Doll, K Fox, D Julian, P Meier, E Sandoya, JE Perez, None, ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction. The Lancet. ,vol. 345, pp. 669- 685 ,(1995)
Henry Han, Howard Chao, Andres Guerra, Alan Sosa, Georgios Christopoulos, Georgios E. Christakopoulos, Bavana V. Rangan, Spyros Maragkoudakis, Hani Jneid, Subhash Banerjee, Emmanouil S. Brilakis, Evolution of the American College of Cardiology/American Heart Association Clinical Guidelines Journal of the American College of Cardiology. ,vol. 65, pp. 2726- 2734 ,(2015) , 10.1016/J.JACC.2015.04.050
Eric R. Siemers, Karen L. Sundell, Christopher Carlson, Michael Case, Gopalan Sethuraman, Hong Liu-Seifert, Sherie A. Dowsett, Michael J. Pontecorvo, Robert A. Dean, Ronald Demattos, Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients Alzheimers & Dementia. ,vol. 12, pp. 110- 120 ,(2016) , 10.1016/J.JALZ.2015.06.1893
David L. DeMets, Susan Smith Ellenberg, Thomas R. Fleming, Data Monitoring Committees in Clinical Trials: A Practical Perspective ,(2002)